Active Pharmaceutical Ingredients (APIs)

Booth No: M314

Characteristic

We provide the high quality active pharmaceutical ingredients globally. We are one of the leading manufacturers of active pharmaceutical ingredients in the world.
Alfacalcidol, EP (EU, TW, CN, SA, IN, RU, JP)
Balsalazide Disodium Dihydrate (US, TW)
Benzonatate, USP (US, TW, CN, KR)
Calcifediol, EP (CEP, US)
Calcipotriol Anhydrous, EP, USP (TW, US, CN, CEP, IN, CA, BY, EU)
Calcipotriol Monohydrate, EP, USP (US, CEP, IN, TW, TR, BY, DZ, MY, CN, CA, PH, AU)
Calcitriol, EP, USP (US, CEP, TW, CA, KR, IN, PK, BR, MX, JP, CN, EU)
Capsaicin, USP (US, EU, TW, TR, CA, CN, UK)
Colesevelam HCl (US, TW, IN, TR, CN, EU, CA)
Colestipol HCl, USP (US, TW)
Doxercalciferol, USP (US, TW)
Elagolix Sodium (US)
Fludiazepam (TW)
Gadoterate Meglumine (US, TR, CN, EU, TW)
Gimeracil (TW, JP, KR)
Oteracil (TW, JP, KR)
Tegafur (TW, JP, KR)
Imatinib Mesylate, EP (TW, US)
Leflunomide, EP, USP (US, CEP, TW, CA, BR, RU, NZ)
Levonorgestrel, EP (US, TW, ZA, KZ, JP, UA, KR, BR, EU)
Linezolid (US, EU, JP, CA, AU, TW, BR, KR, MY, ZA, CN, UK)
Maxacalcitol (JP, TW)
Mifepristone, USP (TW, US)
Mycophenolate Mofetil, EP, USP (US, TW, IN, RU, KR, EU, AU, UK)
Mycophenolate Sodium (US)
Nintedanib Esylate (US, TW, EU)
Nonivamide (EU, RU, TW)
Paricalcitol, USP (US, EU, TW, CN, KR, IN, IL, TR, MY, MK, NZ, BR)
Patiromer Sorbitex Calcium (US)
Pazopanib HCl (TW, US, UA, KR, CN, CA, EU, NZ, SG, ZA, BR, CH, UK)
Rucaparib Camsylate (US)
Sevelamer Carbonate (US, EU, TW, CA, IN, TR, AR, AU,CN, MY, KR, SG, SA, IL, TH, ZA, CH, UK)
Sevelamer HCl (US, TW, CA)
Taltirelin Hydrate (JP)
Temozolomide, EP, USP (US, RU, TW, KR, SG, CA, AU, CN, JP, BR, CEP, MX, CH, EU)
Teriflunomide (US, AU, TR, IL, CA, EU, RU, UK, CH)

Please be reminded that some products listed above are still patented and can only be made available for R & D use as permitted under 35 USC ¶ 271 (e) (1); Article 69, Paragraph 1 of the Patent Act of Japan; Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004; or Article 69 (5) of the Patent Law of People’s Republic of China; or Article 60 of the Patent Act of Republic of China. We will not make, sell, offer for commercial sale or export the products listed above in/into regions or countries in which substance patents are still existing and we will not be responsible if the use of any of the above products infringes on any patent in your country.